Nicole Kidman, Sera Labs Strategic Business Partner/Global Brand Ambassador and Nancy Duitch, Sera Labs Founder/CEO Headline Collision 2021
Kidman and Duitch to discuss how cutting-edge delivery system technology will revolutionize the beauty industry
Sera Labs, a subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR) announced today that Academy Award, Golden Globe and Emmy Award-winning actor/producer/ entrepreneur Nicole Kidman and Sera Labs CEO/CURE Pharmaceutical Chief Strategic Officer, Nancy Duitch will headline Collision 2021. Collision is North America’s fastest-growing tech conference and brings together the world’s most sought-after founders, tech companies, and game-changing entrepreneurs of our time.
Sera Labs and CURE Pharmaceutical have the technology and are poised to set the new standard that will change how the world utilizes beauty, health and wellness products. Kidman and Duitch will discuss how cutting-edge delivery system technology, over a decade’s worth of research and development, seventeen published patents, and extensive expertise in proprietary encapsulation and polymer methodologies, which are fused into Sera Labs’ anti-aging beauty, health and wellness products, will demand attention and accomplish this beauty revolution.
“Speaking with Nicole at Collision is a milestone moment for the brand. Science and technology have always been cornerstones for our company success. The world watches what happens at Collison. We are excited to be there and share more about our cutting-edge anti-aging beauty technology,” said Duitch, Sera Labs CEO/Founder and CURE Pharmaceutical Chief Strategic Officer.
Collision will take place virtually on its proprietary software from April 20-22, 2021 and is expected to attract over 40,000 attendees from over 100 countries. To learn more about the Collision Conference, visit the website. Kidman and Duitch will be headlining day two of the conference.